KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Share-based Compensation (2016 - 2025)

Acadia Pharmaceuticals has reported Share-based Compensation over the past 16 years, most recently at $13.2 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $13.2 million for Q4 2025, up 26.65% from a year ago — trailing twelve months through Dec 2025 was $52.1 million (down 22.24% YoY), and the annual figure for FY2025 was $52.1 million, down 22.24%.
  • Share-based Compensation for Q4 2025 was $13.2 million at Acadia Pharmaceuticals, roughly flat from $13.2 million in the prior quarter.
  • Over the last five years, Share-based Compensation for ACAD hit a ceiling of $26.2 million in Q3 2024 and a floor of $10.4 million in Q4 2024.
  • Median Share-based Compensation over the past 5 years was $14.9 million (2022), compared with a mean of $15.9 million.
  • Biggest five-year swings in Share-based Compensation: soared 41.13% in 2024 and later crashed 49.63% in 2025.
  • Acadia Pharmaceuticals' Share-based Compensation stood at $12.9 million in 2021, then rose by 11.91% to $14.4 million in 2022, then increased by 25.04% to $18.0 million in 2023, then crashed by 42.02% to $10.4 million in 2024, then grew by 26.65% to $13.2 million in 2025.
  • The last three reported values for Share-based Compensation were $13.2 million (Q4 2025), $13.2 million (Q3 2025), and $14.3 million (Q2 2025) per Business Quant data.